158 related articles for article (PubMed ID: 12824927)
1. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Tanaka K; Kondo K; Shinkai M; Honda H; Matsumoto K; Saida T; Kobayashi T
Cancer Sci; 2003 Mar; 94(3):308-13. PubMed ID: 12824927
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
[TBL] [Abstract][Full Text] [Related]
3. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes.
Suzuki M; Shinkai M; Honda H; Kobayashi T
Melanoma Res; 2003 Apr; 13(2):129-35. PubMed ID: 12690295
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Gene Ther; 2003 Dec; 10(12):918-25. PubMed ID: 14712318
[TBL] [Abstract][Full Text] [Related]
6. Combined local hyperthermia and immunotherapy treatment of an experimental subcutaneous murine melanoma.
Geehan DM; Fabian DF; Lefor AT
J Surg Oncol; 1995 May; 59(1):35-9. PubMed ID: 7745975
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
Bonnekoh B; Greenhalgh DA; Chen SH; Block A; Rich SS; Krieg T; Woo SL; Roop DR
J Invest Dermatol; 1998 Jun; 110(6):867-71. PubMed ID: 9620291
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
Int J Cancer; 2005 Sep; 116(4):624-33. PubMed ID: 15825167
[TBL] [Abstract][Full Text] [Related]
10. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
Domingo-Musibay E; Heun JM; Nevala WK; Callstrom M; Atwell T; Galanis E; Erickson LA; Markovic SN
Oncologist; 2017 Sep; 22(9):1026-e93. PubMed ID: 28679643
[TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro.
Fujimoto T; O'Donnell MA; Szilvasi A; Yang H; Duda RB
Cancer Immunol Immunother; 1996 Jun; 42(5):280-4. PubMed ID: 8706049
[TBL] [Abstract][Full Text] [Related]
13. Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
Miguel A; Herrero MJ; Sendra L; Botella R; Algás R; Sánchez M; Aliño SF
Cancer Gene Ther; 2013 Oct; 20(10):576-81. PubMed ID: 23969885
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
16. Enhanced adjuvant effect of granulocyte-macrophage colony-stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity.
Aruga A; Tanigawa K; Aruga E; Yu H; Chang AE
Cancer Gene Ther; 1999; 6(1):89-95. PubMed ID: 10078968
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in mice.
Gołab J; Stokłosa T; Zagozdzon R; Kaca A; Kulchitska LA; Feleszko W; Kawiak J; Hoser G; Głowacka E; Dabrowska A; Giermasz A; Lasek W; Jakóbisiak M
Tumour Biol; 1998; 19(2):77-87. PubMed ID: 9486559
[TBL] [Abstract][Full Text] [Related]
18. Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.
Thompson RC; Pardoll DM; Jaffee EM; Ewend MG; Thomas MC; Tyler BM; Brem H
J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):405-13. PubMed ID: 9041459
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte activation gene-3 fusion protein increases the potency of a granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy.
Li B; VanRoey M; Triebel F; Jooss K
Clin Cancer Res; 2008 Jun; 14(11):3545-54. PubMed ID: 18519788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
